SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001485003-20-000087
Filing Date
2020-08-10
Accepted
2020-08-10 16:19:55
Documents
70
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sesn-20200630.htm   iXBRL 10-Q 1502273
2 EX-31.1 sesn-06302020x10qex311.htm EX-31.1 14590
3 EX-31.2 sesn-06302020x10qex312.htm EX-31.2 14515
4 EX-32.1 sesn-06302020x10qex321.htm EX-32.1 8433
5 EX-32.2 sesn-06302020x10qex322.htm EX-32.2 8398
  Complete submission text file 0001485003-20-000087.txt   6597554

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20200630.xsd EX-101.SCH 46950
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sesn-20200630_cal.xml EX-101.CAL 48620
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sesn-20200630_def.xml EX-101.DEF 219510
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20200630_lab.xml EX-101.LAB 545566
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20200630_pre.xml EX-101.PRE 354743
11 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20200630_htm.xml XML 1140377
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 201089636
SIC: 2834 Pharmaceutical Preparations